Upregulation of human angiotensinogen (AGT) gene transcription by interferon-gamma: Involvement of the STAT1-binding motif in the AGT promoter

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1759, Issue 7, 2006, Pages 340-347

  Jain, Sudhir ^a   Shah, Mehul ^a   Li, Yanna ^a   Vinukonda, Govindaiah ^a   Sehgal, Pravin B ^a   Kumar, Ashok ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cytokine; Gene regulation; Inflammation; Transcription factor

Indexed keywords

ACUTE PHASE PROTEIN; ANGIOTENSINOGEN; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; STAT1 PROTEIN; STAT3 PROTEIN;

ACUTE PHASE RESPONSE; AGT GENE; ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD PRESSURE REGULATION; CHROMATIN IMMUNOPRECIPITATION; DNA RESPONSIVE ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION; LIVER CELL; MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ANGIOTENSINOGEN; BINDING SITES; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; SEQUENCE DELETION; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 33748292814     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2006.07.003     Document Type: Article

References (22)

1. Walker W.G., Whelton P.K., Saito H., Russell R.P., and Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1 (1979) 287-291
2. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Lifton R.P., Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R., Lalouel J.M., et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 71 (1992) 169-180
3. Corvol P., and Jeunemaitre X. Molecular genetics of human hypertension: role of angiotensinogen. Endocr. Rev. 18 (1997) 662-677
4. Campbell D.J., and Habener J.F. Angiotensinogen gene is expressed and differentially regulated in multiple tissuesof the rat. J. Clin. Invest. 78 (1986) 31-39
5. Campbell D.J., and Habener J.F. Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 121 (1987) 1616-1626
6. Griendling K.K., Ushio-Fukai M., Lassegue B., and Alexander R.W. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 29 (1997) 366-373
7. Peach M.J., and Dostal D.E. The angiotensin II receptor and the actions of angiotensin II. J. Cardiovasc. Pharmacol. 16 Suppl. 4 (1990) S25-S30
8. Jamaluddin M., Meng T., Sun J., Boldogh I., Han Y., and Brasier A.R. Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation. Mol. Endocrinol. 14 (2000) 99-113
9. Sherman C.T., and Brasier A.R. Role of signal transducers and activators of transcription 1 and -3 in inducible regulation of the human angiotensinogen gene by Interleukin-6. Mol. Endocrinol. 15 (2001) 441-457
10. Balk R.A. Steroids for septic shock: back from the dead? (Pro). Chest 123 (2003) 490S-499S
11. Keh D., Boehnke T., Weber-Cartens S., Schulz C., Ahlers O., Bercker S., Volk H.D., Doecke W.D., Falke K.J., and Gerlach H. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am. J. Respir. Crit Care Med. 167 (2003) 512-520
12. Jain S., Li Y., Patil S., and Kumar A. A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity. J. Mol. Med. 83 (2005) 121-131
13. Narayanan C.S., Cui Y., and Kumar A. DBP binds to the proximal promoter and regulates liver-specific expression of the human angiotensinogen gene. Biochem. Biophys. Res. Commun. 251 (1998) 388-393
14. Jain S., Tang X., Narayanan C.S., Agarwal Y., Peterson S.M., Brown C.D., Ott J., and Kumar A. Angiotensinogen gene polymorphism at - 217 affects basal promoter activity and is associated with hypertension in African-Americans. J. Biol. Chem. 277 (2002) 36889-36896
15. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
16. Gorzelniak K., Engeli S., Janke J., Luft F.C., and Sharma A.M. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J. Hypertens. 20 (2002) 965-973
17. Brasier A.R., and Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27 (1996) 465-475
18. Eklund A., Leppaniemi A., Kemppainen E., and Pettila V. Vasodilatory shock in severe acute pancreatitis without sepsis: is there any place for hydrocortisone treatment?. Acta Anaesthesiol. Scand. 49 (2005) 379-384
19. Annane D., Sebille V., Charpentier C., Bollaert P.E., Francois B., Korach J.M., Capellier G., Cohen Y., Azoulay E., Troche G., Chaumet-Riffaut P., and Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
20. Briegel J., Forst H., Haller M., Schelling G., Kilger E., Kuprat G., Hemmer B., Hummel T., Lenhart A., Heyduck M., Stoll C., and Peter K. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit. Care Med. 27 (1999) 723-732
21. Bollaert P.E., Charpentier C., Levy B., Debouverie M., Audibert G., and Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit. Care Med. 26 (1998) 645-650
22. Sprung C.L., Caralis P.V., Marcial E.H., Pierce M., Gelbard M.A., Long W.M., Duncan R.C., Tendler M.D., and Karpf M. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N. Engl. J. Med. 311 (1984) 1137-1143